Diabetes Worsens Survival Outcomes in Bladder Cancer Patients: Study Dr Riya Dave17 Dec 2025 11:00 PM ISTResearchers have found in a Finnish population-based cohort study that diabetes and poor glycemic status were associated with a higher risk of overall...
Diabetes Drug Bladder Cancer Risk Debate: Madras HC Orders Expert Review on Pioglitazone, Sitagliptin Safety Susmita Roy16 Dec 2025 3:30 PM ISTNew Delhi: The Madras High Court has directed the Union Ministry of Health and Family Welfare to constitute a team of medical experts to examine the...
A simple urine test could revolutionize bladder cancer diagnosis and treatment, reveals research Dr. Kamal Kant Kohli9 Dec 2025 8:15 PM ISTResearchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose...
USC study suggests type 1 diabetes may significantly raise bladder cancer risk Dr. Kamal Kant Kohli4 Dec 2025 11:30 AM ISTPeople with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, according to a systematic...
USFDA nod to Padcev plus Keytruda for certain patients with bladder cancer: Pfizer, Astellas Pharma Ruchika Sharma22 Nov 2025 12:13 PM ISTNew York: Pfizer and Astellas Pharma have announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (enfortumab...
Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer Ruchika Sharma25 Oct 2025 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has...
Inflammation Markers Help Predict AKI After Bladder Cancer Surgery, reports study Dr Riya Dave5 Oct 2025 8:30 PM ISTResearchers have identified in a new study that perioperative dynamic alterations in systemic inflammatory markers are highly correlated with acute...
Radiation therapy after surgery safely reduces pelvic relapse risk from locally advanced, muscle-invasive bladder cancer: Study Dr. Kamal Kant Kohli2 Oct 2025 9:00 PM ISTRadiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer,...
JnJ bags USFDA nod for bladder cancer treatment Inlexzo Ruchika Sharma10 Sept 2025 11:46 AM ISTRaritan: Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for INLEXZO (gemcitabine intravesical...
Padcev plus Keytruda significantly improves survival for certain patients with bladder cancer when given before, after surgery: Pfizer Ruchika Sharma17 Aug 2025 10:30 AM ISTNew York: Pfizer Inc. and Astellas Pharma Inc. have announced positive topline results from the Phase 3 EV-303 clinical trial (also known as...
JnJ gets USFDA priority review for TAR 200 NDA in high-risk non-muscle invasive bladder cancer Ruchika Sharma19 July 2025 10:30 AM ISTRaritan: Johnson & Johnson has received priority review from the U.S. Food and Drug Administration (FDA) for the New Drug Application...
AstraZeneca Imfinzi approved in EU for muscle-invasive bladder cancer Ruchika Sharma6 July 2025 11:00 AM ISTCambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult patients...
